uti and glp-1 Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Heart Disease: Effect, Safety, Outcomes GLP-1 Medicines And Gut Bacterial
Description
Methods In this open-label, single-center, casecontrol pilot study, patients with IIH (pwIIH) and a body mass index (BMI) of30 kg/m2 were offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM)
The answer isn't the same for everyone
Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)
Novo Nordisks Wegovy and Eli Lillys Zepbound are mentioned in new guidelines from US cardiologists as drugs to consider for preventing cardiovascular disease.
Former seven-time Mr
